February 2020

CYTOO and AskBio enter into research agreement to screen gene therapy candidates for rare muscle disorder
28 February 2020
Grenoble, France and Research Triangle Park, NC, 28 February, 2020 CYTOO, a leading drug discovery company on muscle disorders, today announced that it has entered into a research collaboration aimed at selecting a gene therapy candidate for a rare muscle disorder with Asklepios BioPharmaceutical, Inc. (AskBio), a clinical-stage, fully integrated adeno-associated virus (AAV) gene therapy company. Under the terms of the agreement, AskBio and CYTOO will work together to develop an AAV-based screening platform derived from patient cells. The goal of the collaboration is to screen and select a...
Download info read more